Cargando…
BMPR2 expression is suppressed by signaling through the estrogen receptor
BACKGROUND: Studies in multiple organ systems have shown cross-talk between signaling through the bone morphogenetic protein receptor type 2 (BMPR2) and estrogen pathways. In humans, pulmonary arterial hypertension (PAH) has a female predominance, and is associated with decreased BMPR2 expression. T...
Autores principales: | Austin, Eric D, Hamid, Rizwan, Hemnes, Anna R, Loyd, James E, Blackwell, Tom, Yu, Chang, Phillips III, John A, Gaddipati, Radhika, Gladson, Santhi, Gu, Everett, West, James, Lane, Kirk B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310853/ https://www.ncbi.nlm.nih.gov/pubmed/22348410 http://dx.doi.org/10.1186/2042-6410-3-6 |
Ejemplares similares
-
Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
por: West, James, et al.
Publicado: (2020) -
Oxidative injury is a common consequence of BMPR2 mutations
por: Lane, Kirk L., et al.
Publicado: (2011) -
Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance
por: West, James, et al.
Publicado: (2008) -
Physiologic and molecular consequences of endothelial Bmpr2 mutation
por: Majka, Susan, et al.
Publicado: (2011) -
The genetics of pulmonary arterial hypertension in the post-BMPR2 era
por: Fessel, Joshua P., et al.
Publicado: (2011)